For the Inventor, By the Inventor

Enter inventor name

Los Angeles, CA, United States of America

Ming Yan

USPTO Granted Patents = 12 (Patent Applications = 14)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 32(Granted Patents)

Location History:

Los Angeles, CA (US) (2016 - 2022)
Encino, CA (US) (2017 - 2023)

Company Filing History:

8 out of 15,488

University of California

Csl Behring Gene Therapy, Inc.

Csl Gene Therapy Pty Ltd.

Calimmune, Inc.

Calimmune Australia Pty Ltd

where one patent can have more than one assignee

Years Active: 2016-2023

Loading Chart...

Loading Chart...

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11795461 - Compositions and methods for treating beta-hemoglobinopathies (2023-10-24),

2. 11253483 - Protease assisted native-protein delivery approach (PANDA) (2022-02-22),

3. 11213548 - Modulatable switch for selection of donor modified cells (2022-01-04),

4. 10961537 - Compositions and methods for treating beta-hemoglobinopathies (2021-03-30),

5. 10568844 - RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules (2020-02-25),

6. 10434069 - Protease assisted native-protein delivery approach (PANDA) (2019-10-08),

7. 10426798 - Modulatable switch for selection of donor modified cells (2019-10-01),

8. 10179112 - Viral vector nanocapsule for targeting gene therapy and its preparation (2019-01-15),

9. 10016490 - Multiple-enzyme nanocomplexes (2018-07-10),

10. 9782357 - RNAi molecule delivery platform based on single-siRNA and shRNA nanocapsules (2017-10-10),

11. 9289504 - Single protein nanocapsules for protein delivery with long-term effect (2016-03-22),

12. 9283194 - Methods for protease assisted protein delivery (2016-03-15),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…